AP-001

DB18511ExperimentalSmall molecule

AP-001: Overview.

Mechanism: Pharmacologically active on Peroxisome proliferator-activated receptor alpha, Peroxisome proliferator-activated receptor gamma, and Prosaposin receptor GPR37
Curator reviewed
Formula / weight: C₂₂H₃₂O₄ · 360.494 g/mol (avg)
Also known as: (4Z,7Z,10R,11E,13E,15Z,17S,19Z) 10,17-DIHYDROXY-DOCOSA-4,7,11,13,15,19-HEXAENOIC ACID · 4,7,11,13,15,19-DOCOSAHEXAENOIC ACID, 10,17-DIHYDROXY-, (4Z,7Z,10R,11E,13E,15Z,17S,19Z)- · NEUROPROTECTIN D1 · NPD-1 · PROTECTIN D1
Code names: AP-001

Resolves to

Compound

Structure

InChIKeyCRDZYJSQHCXHEG-SFVBTVKNSA-NSMILESCC\C=C/C[C@H](O)\C=C/C=C/C=C/[C@H](O)C\C=C/C\C=C/CCC(O)=O

Targets

What you can answer from here — as of August 30, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with AP-001, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.